Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial

التفاصيل البيبلوغرافية
العنوان: Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial
المؤلفون: Roof, Elizabeth, Deal, Cheri L, McCandless, Shawn E, Cowan, Ronald L, Miller, Jennifer L, Hamilton, Jill K, Roeder, Elizabeth R, McCormack, Shana E, Roshan Lal, Tamanna R, Abdul-Latif, Hussein D, Haqq, Andrea M, Obrynba, Kathryn S, Torchen, Laura C, Vidmar, Alaina P, Viskochil, David H, Chanoine, Jean-Pierre, Lam, Carol K L, Pierce, Melinda J, Williams, Laurel L, Bird, Lynne M, Butler, Merlin G, Jensen, Diane E, Myers, Susan E, Oatman, Oliver J, Baskaran, Charumathi, Chalmers, Laura J, Fu, Cary, Alos, Nathalie, McLean, Scott D, Shah, Ajay, Whitman, Barbara Y, Blumenstein, Brent A, Leonard, Sarah F, Ernest, Jessica P, Cormier, Joseph W, Cotter, Sara P, Ryman, Davis C
المصدر: The Journal of Clinical Endocrinology & Metabolism; July 2023, Vol. 108 Issue: 7 p1696-1708, 13p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0021972X
19457197
DOI:10.1210/clinem/dgad015